05th week of 2013 patent applcation highlights part 52 |
Patent application number | Title | Published |
20130030123 | Artificial Turf Yarn - Provided is an artificial turf yarn having improved heat resistance, durability, softness and extensibility. The artificial turf yarn contains two components: an olefin block copolymer (OBC) and a linear low density polyethylene (LLDPE). The yarn includes from about 10 wt % to about 80 wt % of the OBC and from about 20 wt % to about 90 wt % of the LLDPE which produces an artificial turf yarn with improved softness and toughness while maintaining heat resistance. | 2013-01-31 |
20130030124 | THERMOPLASTIC ELASTOMER COMPOSITION AND MANUFACTURING METHOD THEREFOR - A thermoplastic elastomer composition having a continuous phase and a dispersed phase, wherein the continuous phase comprising (A) an epoxy-modified polyamide resin, and the dispersed phase comprising (B) a halogenated isoolefin-paraalkylstyrene copolymer rubber, wherein the thermoplastic elastomer composition is obtained by melt-kneading (B) halogenated isoolefin-paraalkylstyrene copolymer rubber, (C) a polyamide resin, and (D) a polyfunctional epoxy compound having two or more epoxy groups per molecule in an amount of 0.05 parts by weight or more and less than 3 parts by weight with respect to 100 parts by weight of polyamide resin (C), at a temperature which is equal to or more than the melting point of polyamide resin (C), and epoxy-modified polyamide resin (A) is produced by the reaction of polyamide resin (C) with polyfunctional epoxy compound (D) during the melt-kneading. | 2013-01-31 |
20130030125 | MOULDING COMPOSITION - A polyethylene moulding composition having a multimodal molecular weight distribution, having a density according to ISO 1183 at 23° C. in the range of 920 to 960 kg/m | 2013-01-31 |
20130030126 | Olefin Functionalization By Metathesis Reaction - This invention relates to a process to functionalize propylene co-oligomer comprising contacting an alkene metathesis catalyst with a heteroatom containing alkene, and a propylene a co-oligomer having an Mn of 300 to 30,000 g/mol comprising 10 to 90 mol % propylene and 10 to 90 mol % of ethylene, wherein the oligomer has at least X % allyl chain ends, where: 1) X=(−0.94 (mol % ethylene incorporated)+100), when 10 to 60 mol % ethylene is present in the co-oligomer, and 2) X=45, when greater than 60 and less than 70 mol % ethylene is present in the co-oligomer, and 3) X=(1.83*(mol % ethylene incorporated)−83), when 70 to 90 mol % ethylene is present in the co-oligomer. This invention also relates to a process to functionalize propylene homo-oligomer comprising contacting an alkene metathesis catalyst with a heteroatom containing alkene, and a propylene homo-oligomer, comprising propylene, wherein the oligomer has: at least 93% allyl chain ends, an Mn of about 500 to about 20,000 g/mol, an isobutyl chain end to allylic vinyl group ratio of 0.8:1 to 1.2:1.0, and less than 100 ppm aluminum. | 2013-01-31 |
20130030127 | STAR POLYMER AND METHOD OF PRODUCING SAME - The present invention provides a styrene-based star polymer with narrow dispersion and suitable as a resist material, etc. A star polymer of the present invention is represented by the formula A[C(Y)X | 2013-01-31 |
20130030128 | THERMOPLASTIC COMPOSITION FORMED FROM POLYLACTIC ACID AND ELASTOMERIC GRAFT COPOLYMER - The brittleness of a thermoplastic material containing a polylactic acid may be reduced by melting and mixing the thermoplastic material and a graft copolymer to link the graft copolymer to thermoplastic polymer to form a new thermoplastic material with reduced brittleness. The graft copolymer comprises an elastomeric backbone and a side chain grafted to the backbone. The side chain comprises a enantiomer of lactic acid opposite to the enantiomer in the thermoplastic material. A composition comprises a thermoplastic polymer and the graft copolymer, where the graft copolymer is linked to the thermoplastic polymer by the enantiomers. A method of forming the composition may comprise melting precursors for the thermoplastic polymer and the graft copolymer, and mixing the precursors to allow the lactic acids to link the graft copolymer to the thermoplastic polymer. | 2013-01-31 |
20130030129 | MANUFACTURING METHOD OF POLY LACTIC ACID STEREOCOMPLEX USING SOLVENT CASTING METHOD - Disclosed is a method for manufacturing a polylactic acid film. More specifically, the present invention relates to a method for stably and effectively obtaining optimized stereocomplex crystals through specified boiling point and evaporation time of a solvent allowing the content of stereocomplex crystals to be 100%. | 2013-01-31 |
20130030130 | METHOD FOR PRODUCING BLOCK POLYMER, BLOCK POLYMERS, AND SURFACE TREATMENT AGENT - A method for producing block polymers which involves (i) a step for obtaining a polymer of first monomers by means of a first polymerization reaction to polymerize the first monomers in the presence of an alkoxyamine catalyst, and (ii) a step for obtaining a block polymer by means of a second polymerization reaction to polymerize second monomers in the presence of an alkoxyamine catalyst and the polymers of the first monomers, wherein at least one of the kinds of monomers is a fluorinated (meth)acrylate monomer. | 2013-01-31 |
20130030131 | Reactive Amine-Functional Silicone-Polyether Block Copolymers - Silicone-polyether block copolymers are disclosed, having the average formula: R | 2013-01-31 |
20130030132 | PROCESS FOR PREPARING POLYOLEFIN - The invention relates to a process for preparing polyolefin in a loop reactor. The polymer is prepared by polymerizing olefin monomers in the presence of a catalyst to produce a polyolefin slurry while pumping said slurry through said loop reactor by means of a pump. The present process is characterized in that the catalyst is fed in the loop reactor at a distance to the pump. The invention allows production of the polymer with advantageous properties while leading to fewer blockages of the reactor. | 2013-01-31 |
20130030133 | ANIONIC POLYMERIZATION METHODS FOR PRODUCING FUNCTIONALIZED POLYMERS - A process for producing functional polymer, the process comprising the steps of reacting an anionic initiator including a functional group with a stabilizing monomer to produce a stabilized initiator, reacting the stabilized initiator with monomer capable of being anionically polymerized to produce a polymer, and terminating the polymer. | 2013-01-31 |
20130030134 | ZIEGLER CATALYST AND METHOD OF SYNTHESIZING THE SAME - The various embodiments herein disclose a method for making a Zieglaer catalyst including a reaction product of a dispersed magnesium alkoxide or a dispersed mixture of magnesium alkoxide and silica with a transition metal compound of titanium, zirconium, vanadium or chromium, and a chlorine containing organoaluminum mixed together with two additional components comprising a halogen containing silicon compound and aliphatic primary halogenated hydrocarbons respectively. The embodiments also provide a method of polymerization of 1-olefin monomers using the Ziegler catalyst. | 2013-01-31 |
20130030135 | Vinyl-Terminated Macromonomer Oligomerization - Vinyl-terminated macromonomer oligomerization, namely, a process to produce polymacromonomers comprising contacting a vinyl-terminated macromonomer with a catalyst system capable of oligomerizing vinyl-terminated macromonomer, in the presence of an aluminum containing compound, a zinc containing compound, or a combination thereof, under polymerization conditions to produce a polymacromonomer, and polymacromonomers produced thereby. Also, polymacromonomers having a degree of polymerization greater than 10, a glass transition temperature Tg of less than 60° C., and an Mn of greater than or equal to about 5000 Da. | 2013-01-31 |
20130030136 | OPTICAL MATERIAL AND MOLDED PRODUCT THEREOF - Disclosed is an optical material including a cyclic olefin copolymer containing at least a repeating structural unit [A] represented by the general formula (1) and a repeating structural unit [B] represented by the general formula (2) and having a molar ratio [A]/[B] of from 95/5 to 1/99, wherein the absolute value of the ratio ΔOB/ΔF is from 0.001 to 0.250 in which ΔOB represents the amount of a change in the absolute value of the orientation birefringence calculated from the phase difference (nm) at a wavelength of | 2013-01-31 |
20130030137 | Propylene-Based Terpolymers For Films - A propylene/ethylene/1-hexene terpolymer containing from 1.0 wt% to 2.5 wt %, of ethylene derived units and from 2.0 wt % to 4.0 wt % of 1-hexene derived units, the sum of the amounts of propylene, ethylene and 1-.hexene derived units being 100, having the following features:
| 2013-01-31 |
20130030138 | METHOD FOR PRODUCING ORGANOPOLYSILOXANE COMPOUND - The present invention relates to a method for producing an organopolysiloxane compound having a structure in which a poly(N-acylalkylene imine) segment containing a repeating unit represented by the following general formula (1) is bonded to a terminal end and/or a side chain of an organopolysiloxane segment, the method including the steps of (a) subjecting a cyclic iminoether compound represented by the following general formula (I) to ring opening polymerization in a solvent to prepare a solution of a terminal-reactive poly(N-acylalkylene imine); (b) mixing a modified organopolysiloxane containing an amino group bonded to a terminal end and/or a side chain of a molecular chain thereof with a solvent to prepare a solution of the modified organopolysiloxane; (c) mixing the terminal-reactive poly(N-acylalkylene imine) solution prepared in the step (a) with the modified organopolysiloxane solution prepared in the step (b) to react the amino group contained in the modified organopolysiloxane with the terminal-reactive poly(N-acylalkylene imine); (d) adding a basic substance to a reaction product obtained in the step (c); and (e) removing the solvents from a mixture obtained after the addition in the step (d) at a temperature of from 100 to 200° C.: | 2013-01-31 |
20130030139 | DENDRITIC POLYMERS AND MAGNETIC RESONANCE IMAGING CONTRAST AGENT EMPLOYING THE SAME - A dendritic polymer and a magnetic resonance imaging contrast agent employing the same. The magnetic resonance contrast agent includes the dendritic polymer according to the structure of SP-DZ-L) | 2013-01-31 |
20130030140 | POLYOL FOR POLYURETHANE PREPARATION AND POLYURETHANE PREPARATION METHOD USING SAME - A polyol (PL) for polyurethane preparation is disclosed that includes the polyol (a) and the strength-enhancing agent (b), as follows. Polyol (a): a polyoxyalkylene polyol that is the alkylene oxide adduct of an active hydrogen-containing compound (H), in which at least 40% of a hydroxyl group positioned on the terminal is a primary hydroxyl group-containing group represented by general formula (I). In general formula (I), R | 2013-01-31 |
20130030141 | METHOD FOR PRODUCING LIQUID-CRYSTALLINE POLYESTER - The present invention provides a method for producing a liquid-crystalline polyester, which comprises melt-polymerizing monomers in a reactor having a draw outlet to obtain a polymer melt and drawing the polymer melt through the draw outlet, characterized in that the monomers comprise a compound selected from an aromatic hydroxycarboxylic acid and derivatives thereof, a compound selected from an aromatic dicarboxylic acid and derivatives thereof and a compound selected from an aromatic diol, an aromatic hydroxyamine, an aromatic diamine and derivatives thereof; the amount of units derived from a compound containing a 1,2-phenylene and/or a 1,3-phenylene skeleton(s) in the polyester is from 0 to 10 mold; the melt polymerization is performed in the presence of a heterocyclic compound containing two or more nitrogen atoms; and the polymer melt has a flow initiation temperature of from 220 to 250° C. | 2013-01-31 |
20130030142 | METHOD FOR PRODUCING LIQUID-CRYSTALLINE POLYESTER - The present invention provides a method for producing a liquid-crystalline polyester, the method comprising: a step of melt-polymerizing raw monomers in a melt polymerization vessel to obtain a polymer melt; a step of drawing the polymer melt from the melt polymerization vessel and granulating the polymer melt to obtain a granulate; a step of allowing the granulate to undergo solid phase polymerization in a solid phase polymerization vessel to obtain a solid phase polymer; and a step of making an impact on the solid phase polymerization vessel containing the solid phase polymer, and taking out the solid phase polymer from the solid phase polymerization vessel. | 2013-01-31 |
20130030143 | METHOD FOR MANUFACTURING LIQUID CRYSTAL POLYESTER AND LIQUID CRYSTAL POLYESTER - A method for manufacturing a liquid crystal polyester, comprising: a melt polycondensation step in which 0.001 to 1% by mass of a heterocyclic aromatic compound represented by the following formula (I) is added to a monomer mixture comprising at least one monomer selected from the group consisting of terephthalic acid, a terephthalic acid derivative, 2,6-naphthalenedicarboxylic acid and a 2,6-naphthalenedicarboxylic acid derivative, relative to 100% by mass of the monomer mixture, and then a melt polycondensation is conducted at a temperature of 240 to 300° C. so as to obtain a polymer. | 2013-01-31 |
20130030144 | STAR POLYMERS HAVING CONTROLLED TACTICITY AND METHODS OF MAKING SAME - Disclosed is a method for synthesizing star polymers having controlled tacticity. The method comprises reacting a lactone-based monomer having at least one stereocentre and a poly-functional initiator in the presence of at least one catalyst. In particular embodiments, the lactone-based monomer is L-lactide or DL-lactide, the poly-functional initiator is dipentaerythritol, and the at least one catalyst is an aluminum-salen catalyst ( | 2013-01-31 |
20130030145 | BIOMASS-RESOURCE-DERIVED POLYESTER AND PRODUCTION PROCESS THEREOF - The present invention provides a resin capable of contributing greatly to solve environmental problems and problems related to exhaustion of fossil fuel resources and having physical properties suited for practical use. | 2013-01-31 |
20130030146 | PREPARATION OF CAPROLACTAM FROM 6-AMINO CAPROIC ACID OBTAINED IN A FERMENTATION PROCESS - The invention relates to a method for preparing caprolactam comprising recovering a mixture containing 6-aminocaproic acid, from a culture medium comprising biomass, and thereafter cyclising the 6-aminocaproic acid in the presence of superheated steam, thereby forming caprolactam, wherein the weight to weight ratio carbohydrate to 6-aminocaproic acid in said mixture is 0.03 or less. | 2013-01-31 |
20130030147 | MANUFACTURING METHOD OF COLORED POLYLACTIC ACID RESIN - Disclosed is a technique of providing color to a polylactic acid resin which is promising as a plant-derived material for automotive interior/exterior parts. When a polylactic acid material is used as a covering fiber material of an automotive interior part, coloring is necessary for harmonization with other parts in the car. According to the disclosed technique, color is provided to a polylactic acid resin using a combination of a catalyst and an initiator when it is polymerized from lactide. The disclosed method is time-saving and economical since a colored resin can be polymerized and thus the complicated process of dyeing a white resin using a disperse dye and washing and drying the same can be avoided. | 2013-01-31 |
20130030148 | PROCESS FOR THE SYNTHESIS OF (AIB8,35)HGLP-1(7-36)-NH2 - The present invention relates to a process for the large-scale synthesis of (Aib | 2013-01-31 |
20130030149 | PROCESS FOR PURIFICATION OF PNEUMOCANDIN - The process described herein discloses purification process of a secondary metabolite produced by fermentation route. The process involves selective removal of impurities at various stages of washings, charcoalization followed by crystallization. The product is closely related to class of echinocandins and is found to be potent antifungal compound & a key ingredient in the synthesis of antifungal drugs. | 2013-01-31 |
20130030150 | Purification Method of Azacyclohexapeptide or Its Salt - A purification method of the compound represented by formula 1 is provided, which includes the following steps: (1) loading crude compound 1 on macroporous adsorbent resin, (2) washing the macroporous adsorbent resin with an aqueous solution, an organic solvent or a mixture solution of organic solvent and water, (3) eluting with an aqueous solution, an organic solvent or a mixture solution of organic solvent and water. The purified compound represented by formula 1 is obtained. | 2013-01-31 |
20130030151 | RAPID GLYCOPEPTIDE OPTIMIZATION VIA NEOGLYCOSYLATION - The present invention generally relates to methods and compositions for generating vancomycin analogs. Specifically the invention relates to generating a vancomycin library through chemoselective ligation of a sugar moiety with a vancomycin aglycon. In particular, the present invention provides a library of vancomycin analogs, where the member of the library comprises at least one vancomycin analog selected from 2′-N-acyldecanoyl-glucosyl vancomycin neoglycoside, 3′-N-acyldecanoyl-glucosyl vancomycin neoglycoside, 4′-N-acyldecanoyl-glucosyl vancomycin neoglycoside, 6′-N-acyldecanoyl-glucosyl vancomycin neoglycoside, 2′-N-acylbiphenyl-glucosyl vancomycin neoglycoside, 3′-N-acylbiphenoyl-glucosyl vancomycin neoglycoside, 4′-N-acylbiphenoyl-glucosyl vancomycin neoglycoside and 6′-N-acylbiphenoyl-glucosyl vancomycin neoglycoside. | 2013-01-31 |
20130030152 | TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE - Target and method for inhibition of bacterial RNA polymerase disclosed are targets and methods for specific binding and inhibition of RNAP from bacterial species. | 2013-01-31 |
20130030153 | CROSSLINKED HUMAN OR ANIMAL TISSUE PRODUCTS AND THEIR METHODS OF MANUFACTURE AND USE - Degradable bioprostheses made of collagen-based material having amine-based and ester-based crosslinks are provided, as are methods for their formation and use. Some embodiments of the present invention are directed towards a method of controlling the ratio of amine-based crosslinks to ester-based crosslinks within a collagen-based material to provide a tailorably crosslinked collagen-based material. Some embodiments provide a method of making a degradable bioprosthesis involving controlling crosslinking to afford a degradable bioprosthesis that is partially crosslinked. By controlling the ratio of amine-based to ester-based crosslinks, by controlling the level of crosslinking, or by controlling both of these features, degradable bioprostheses with tailored degradation rates can be synthesized. Some embodiments of degradable bioprostheses have degradation rates that are tailored to allow their use in particular medical applications. Some embodiments are directed towards methods of use degradable bioprostheses in wound healing, tissue repair, and tissue supplementation. | 2013-01-31 |
20130030154 | MIXED MODE LIGANDS - Substrates comprising a solid support, a ligand, and a linker comprising at least one C, O, N, or S atom covalently connecting the solid support to the ligand, are disclosed, along with methods of using and making the substrates, and devices including the substrates. | 2013-01-31 |
20130030155 | ANTIBODIES TO THE NOTCH1 RECEPTOR - The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means and methods for the diagnosis, characterization, prognosis and treatment of cancer and specifically targeting cancer stem cells. The present invention provides an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human NOTCH receptor and inhibits growth of tumor cells. The present invention further provides a method of treating cancer, the method comprising administering a therapeutically effective amount of an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human NOTCH receptor protein and inhibits growth of tumor cells. | 2013-01-31 |
20130030156 | ANTI-ILT5 ANTIBODIES AND ILT5-BINDING ANTIBODY FRAGMENTS - Disclosed herein are antibodies and ILT5-binding fragments thereof that specifically bind to ILT5, e.g., human ILT5 (hILT5), and pharmaceutical compositions comprising such ILT5-binding antibodies and ILT5-binding fragments thereof. | 2013-01-31 |
20130030157 | Rodent Combinatorial Antibody Libraries - The present invention provides synthetic rodent antibody libraries, such as mouse or rat antibody libraries, as well as polypeptides, nucleic acids, vectors, host cells and methods used in conjunction with these libraries. The present invention also provides antibodies isolated from such libraries and variants of such antibodies. | 2013-01-31 |
20130030158 | ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME USEFUL FOR INHIBITING ACTIVITY OF METALLOPROTEINS - An antibody comprising an antigen recognition region which comprises CDR amino acid sequences set forth in SEQ ID NO: 7, 8, 9, 10, 11 and 12. | 2013-01-31 |
20130030159 | ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF - The disclosure provides compositions and methods relating to or derived from anti-activin A binding proteins, including antibodies. In particular embodiments, the disclosure provides fully human, humanized, and chimeric anti-activin A antibodies that bind human activin A, activin A-binding fragments and derivatives of such antibodies, and activin A-binding polypeptides comprising such fragments. Other embodiments provide nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having activin A-related disorders or conditions including cachexia related to gonadal cancer, other cancers, rheumatoid arthritis, and other diseases. | 2013-01-31 |
20130030160 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES - Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses. | 2013-01-31 |
20130030161 | PROCEDURE FOR OBTAINING A COMPOSITION CONTAINING GROWTH FACTORS FROM A BLOOD COMPOUND, AND COMPOSITION OBTAINED BY SAID PROCEDURE - Procedure for obtaining a composition that contains growth factors, which comprises the steps of heat-treating a platelet-rich plasma or the supernatant of a platelet-rich plasma that contains released growth factors in order to increase its temperature, for eliminating the complement and reducing the immunoglobulins present therein, and lyophilizing the plasma or supernatant in order to obtain a final dry composition that can easily be transported, handled and stored, thereby facilitating periodic or chronic treatments with blood compounds. It has been shown that when the final dry composition is resuspended, a once again humid composition is obtained that maintains its biological properties intact. | 2013-01-31 |
20130030162 | PROCESS FOR EXTRACTION OF GLUCOSINOLATES FROM BROCCOLI SEEDS - A new process for extracting and purifying glucosinolates from plant material, preferably broccoli sprouts or seeds is described. An alcoholic extract is adsorbed onto a basic resin and eluted with ammonia. Optionally, the alcoholic extract is passed through an ion-exchange column containing acidic resin prior to the adsorption/elution step. | 2013-01-31 |
20130030163 | METHOD FOR ISOLATING AND PURIFYING NUCLEIC ACIDS - The present invention relates to a method for isolating and purifying nucleic acids, preferably comprising genomic DNA, from biological samples comprising the steps of lysing the sample using a lysis buffer comprising a source of anionic surfactant ions, optionally disintegrating the RNA present in the lysate, precipitating the surfactant ions from the lysate, and separating the nucleic acids from the precipitate and further contaminants by size-exclusion chromatography. The invention furthermore relates to a lysis buffer, a method of lysing cells and a kit for the isolation and purification of nucleic acids. | 2013-01-31 |
20130030164 | NADH OXIDASE MUTANT HAVING IMPROVED STABILITY AND USE THEREOF - Water-forming NADH oxidase derived from | 2013-01-31 |
20130030165 | CHROMATOGRAPHIC DEVICE AND METHOD FOR ISOLATING AND PURIFYING NUCLEIC ACIDS - The present invention relates to a chromatographic device for isolating and purifying nucleic acids, preferably genomic DNA, by gel filtration chromatography, a method for isolating and purifying nucleic acids, preferably genomic DNA, using this device and a kit comprising this device. | 2013-01-31 |
20130030166 | MINOR GROOVE BINDER PHOSPHORAMIDITES AND METHODS OF USE - Minor groove binder phosphoramidites having unique structures have been synthesized according to particular methods. These minor groove binder phosphoramidites are useful in the preparation of oligonucleotide conjugates, particularly those for use as probes and primers. | 2013-01-31 |
20130030167 | Production of Resistant Dextrins - A method for producing digestion-resistant dextrin from starch hydrolyzates is disclosed. In one form, the method includes mixing the starch hydrolyzate, dextrose and an acid catalyst which are allowed to react under mild vacuum with heat. The ingredients require no pre-drying and the method requires no external plasticizers. | 2013-01-31 |
20130030168 | Device For Synthesis Of Radiopharmaceutical Products - The invention concerns a device for synthesis of radiopharmaceutical products based on chemical reagents contained in bottles, said device comprising several reaction compartments, transfer means between said bottles and said reaction compartments as well as mechanical means acting on said transfer means and enabling to monitor and control mechanically the transfer of chemical reagents. The invention is characterized in that it comprises: a fixed module including at least the mechanical means; a removable and disposable module, essentially in the shape of a support, whereon are arranged the transfer means between said bottles and said reaction compartments, said removable and disposable module not including any mechanical means; and means for securing said removable and disposable module to said fixed module. | 2013-01-31 |
20130030169 | Process for the Preparation of Drospirenone - A process is described, comprising the oxidation of 17α-(3-hydroxypropyl)-6β,7β,15β,16β-dimethylen-5β-androstan-3β,5,17β-triol, for the preparation of drospirenone, a synthetic steroid with progestogenic, antimineralocorticoid and antiandrogenic activity, useful for preparing pharmaceutical compositions with contraceptive action. | 2013-01-31 |
20130030170 | ENANTIOSELECTIVE CYCLOPROPENATION OF ALKYNES - The cobalt(II) complex of new D2-symmetric chiral porphyrin 3,5-DiMes-ChenPhyrin, [Co(P2)], has been shown to be a highly effective chiral metalloradical catalyst for enantioselective cyclopropenation of alkynes with acceptor/acceptor-substituted diazo reagents such as α-cyanodiazoacetamides and α-cyanodiazoacetates. The [Co(P2)]-mediated metalloradical cyclopropenation is suitable to a wide range of terminal aromatic and related conjugated alkynes with varied steric and electronic properties, providing the corresponding tri-substituted cyclopropenes in high yields with excellent enantiocontrol of the all-carbon quaternary stereogenic centers. In addition to mild reaction conditions, the Co(II)-based metalloradical catalysis for cyclopropenation features a high degree of functional group tolerance. | 2013-01-31 |
20130030171 | Pyrimidinyl Aryl Urea Derivatives being FGF Inhibitors - The invention relates to heteroaryl aryl ureas of the formula IA, | 2013-01-31 |
20130030172 | Methods of Preparing Quinoline Derivatives - Methods of preparing compounds of formula i(1): | 2013-01-31 |
20130030173 | PROCESS FOR THE PREPARATION OF SMALL MOLECULE INHIBITORS OF MDM2 AND INTERMEDIATES USED THEREIN - The invention relates to small molecules which function as inhibitors of the interaction between p53 and MDM2. The invention also relates to the use of these compounds for inhibiting cell growth, inducing cell death, inducing cell cycle arrest and/or sensitizing cells to additional agent(s). | 2013-01-31 |
20130030174 | COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR - Disclosed is a composition effective in reducing skin wrinkles. The composition comprises or uses a phosphodiesterase 5 (PDE5) inhibitor as an active ingredient. Further disclosed is a method for reducing skin wrinkles using the composition. | 2013-01-31 |
20130030175 | METAL-PORPHYRIN CARBON NANOTUBES FOR USE IN FUEL CELL ELECTRODES - The present invention provides metal-porphyrin carbon nanostructures, which have excellent oxygen reduction performance and are useful as materials for fuel cell electrodes. | 2013-01-31 |
20130030176 | PROCESSES FOR PREPARING TICAGRELOR INTERMEDIATE, 4,6-DICHLORO-5-NITRO-2-(PROPYLTHIO)PYRIMIDINE - Provided herein are improved, commercially viable and industrially advantageous processes for the preparation of a substantially pure ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine, Formula (II). The intermediate is useful for preparing ticagrelor, or a pharmaceutically acceptable salt thereof in high yield and purity. | 2013-01-31 |
20130030177 | SYNTHESIS PROCESS OF DASATINIB AND INTERMEDIATE THEREOF - Synthesis process of dasatinib is disclosed, which includes the step of reacting the compound of formula I with that of formula II to obtain the compound of formula III. Also disclosed is the compound of formula III which is used as an intermediate for synthesizing dasatinib. The substituents of R1, R2, R3 or R4 in formulae I, II or III are defined as in the description. | 2013-01-31 |
20130030178 | METHODS OF MAKING HIV ATTACHMENT INHIBITOR PRODRUG COMPOUND AND INTERMEDIATES - A method for making the compound of Formula I: | 2013-01-31 |
20130030179 | PROCESS FOR THE PREPARATION OF VARENICLINE - It is disclosed a process for the preparation of a compound of formula (I) or a salt thereof, comprising: | 2013-01-31 |
20130030180 | Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators - Disclosed are compounds and methods for treating neurological and other disorders by administering to a subject in need thereof an effective amount of a compound having binding and/or modulation specificity for GFRα receptor molecules, which can be mimetics of glial-derived neurotrophic factor (GDNF) family ligands (GFLs), GFRα/RET signaling pathway agonists, and/or direct RET agonists (activators). | 2013-01-31 |
20130030181 | N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors - The invention provides a compound of Formula (I) | 2013-01-31 |
20130030183 | PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND - The object of the present invention is a one-pot process for preparing the 2-acetoxy-5-(2-fluoro-α-cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-tieno[3,2-c]-pyridine (prasugrel) of the formula (I) by reacting the 5,6,7,7a-tetrahydro-4H-tieno[3,2-c]-pyridine-2-on of the formula (II) with 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)-etanone of the formula (III) or with 2-chloro-1-cyclopropyl-2-(2-fluorphenyl)-etanone of the formula (IIIa) and acetylating of the formed compound of the formula (IV), wherein the reaction is carried out in the presence of an organic base with an acetylation agent without isolating the compound of the formula (IV). The coupling and acetylation are carried out in the presence of the same organic base such as triethylamine, N,N-diisopropyl-ethylamine or pyridine. At the end of the process the prasugrel of the formula (I) is purified by recrystallization from an organic solvent or a mixture of solvents. | 2013-01-31 |
20130030184 | ISOTOPICALLY LABELED CHEMICALLY STABLE REAGENTS AND PROCESS FOR THE SYNTHESIS THEREOF - A radioisotope labeled reagent includes a compound having the general formula (I), | 2013-01-31 |
20130030185 | CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND - The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases. | 2013-01-31 |
20130030186 | PROCESS FOR PREPARING SULPHOXIDE COMPOUNDS - A process for the enantioselective synthesis of a sulphoxide of a compound of Formula I or a pharmaceutically acceptable salt thereof in the form of a single enantiomer or in an enantiomerically enriched form | 2013-01-31 |
20130030187 | PROCESS FOR THE PREPARATION OF (R,S)-NICOTINE - A process for (R,S)-nicotine is described. Condensation of 1-(but-1-enyl) pyrrolidin-2-one with nicotinic acid ester gave 1-(but-1-enyl)-3-nicotinoylpynolidin-2-one which on treatment with an acid and a base gave myosmine. Myosmine was converted to (R,S)-nicotine by reduction followed by N-methylation. | 2013-01-31 |
20130030188 | PROCESS FOR THE PREPARATION OF (R,S)-NICOTINE - A process for (R,S)-nicotine is described. Condensation of 1-(but-1-enyl) pyrrolidin-2-one with nicotinic acid ester gave 1-(but-1-enyl)-3-nicotinoylpyrrolidin-2-one which on treatment with an acid and a base gave myosmine. Myosmine was converted to (R,S)-nicotine by reduction followed by N-methylation. | 2013-01-31 |
20130030189 | INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS - Compounds having the formula | 2013-01-31 |
20130030190 | PROCESS FOR SYNTHESIS FIPRONIL - The present disclosure relates to a process for trifluoromethylsulfinyl pyrazole compound of formula I, | 2013-01-31 |
20130030191 | Group IV Metal Complexes For Metal-Containing Film Deposition - Metal-containing complexes with general formula (1) (R | 2013-01-31 |
20130030192 | Method of Synthesizing Acetonide-Protected Catechol-Containing Compounds and Intermediates Produced Therein - The inventors disclose here a novel, facile approach to the synthesis of acetonide-protected catechol-containing compounds having at least one amine group. In specific embodiments, the invention provides novel methods of synthesizing 3,4-dihydroxyphenylalanine (H-DOPA(acetonide)-OH (6)), Fmoc-protected H-DOPA(acetonide)-OH (Fmoc-DOPA(acetonide)-OH (7)), Fmoc-protected dopamine (Fmoc-dopamine(acetonide) (10)), TFA-protected dopamine (TFA-dopamine(acetonide) (13)) and acetonide-protected 4-(2-aminoethyl)benzene-1,2-diol (acetonide-protected dopamine (14)). | 2013-01-31 |
20130030193 | PROCESS FOR PRODUCING WINE LACTONE - The present invention relates to a method comprising (A) reacting a β-keto ester with a 2-halo ester under basic conditions to obtain a 2-aceto-3-methyl-succinic acid ester; (B) reacting the resulting 2-aceto-3-methyl-succinic acid ester with methyl vinyl ketone under basic conditions, optionally followed by a decarboxylation reaction and hydrolysis, etc., to obtain an α-methyl-γ-keto acid; and (C) reducing the resulting α-methyl-γ-keto acid to obtain wine lactone or a stereoisomer thereof or a mixture thereof. Alternatively, the present invention relates to a method comprising step (A) as recited above; (B) reacting the resulting 2-aceto-3-methyl-succinic acid ester with methyl vinyl ketone under basic conditions, followed by decarboxylation reaction to obtain an α-methyl-γ-keto acid ester; and (E) reducing the resulting α-methyl-γ-keto acid ester in the presence of a ruthenium complex having a specific structure and in the presence of a hydrogen donor to obtain wine lactone or a stereoisomer thereof or a mixture thereof. | 2013-01-31 |
20130030194 | Metal Catalyst Composition for Producing Furfural Derivatives from Raw Materials of Lignocellulosic Biomass, and Method for Producing Furfural Derivatives Using the Composition - The present invention relates to a metal catalyst composition for producing furfural derivatives from raw materials of lignocellulosic biomass, and method for producing furfural derivatives using the composition. The present invention comprises ruthenium chloride (RuCl | 2013-01-31 |
20130030195 | Crystalline Minocycline Base and Processes for its Preparation - The invention provides crystalline minocycline base. In particular, three crystalline polymorphic forms, designated Form I, Form II and Form III, of minocycline base are provided. These are characterised by XRD and IR data. Processes for preparing the new polymorphic forms are also provided. For example, Form I is prepared by dissolving and/or suspending amorphous minocycline base in an organic solvent chosen from ethers followed by crystallisation from the mixture. | 2013-01-31 |
20130030196 | PROCESS FOR EXTRACTING SEED OIL COMPRISING GRINDING SEEDS IN A SOLVENT - A process for extracting seed-oil from an oil-containing seed product comprises (a) providing the seed product to a grinder; (b) providing a first liquid comprising a solvent to the grinder; (c) grinding the seed product and the first liquid to yield a slurry; (d) subjecting the slurry to a slurry extraction and slurry separation step to yield a processed seed product and a liquid product comprising seed-oil and solvent; and (e) subjecting the liquid product to an oil separation step to at least partially separate the seed-oil from the solvent. | 2013-01-31 |
20130030197 | FATTY ACYL AMIDO BASED SURFACTANT CONCENTRATES - A surfactant concentrate is provided that includes C | 2013-01-31 |
20130030198 | GENERAL METHOD FOR PREPARING FATTY ACYL AMIDO BASED SURFACTANTS - A process is provided for preparing C | 2013-01-31 |
20130030199 | AMINO ACID SALT CONTAINING COMPOSITIONS - A reagent composition for forming fatty acyl amido surfactants is provided which includes an alkali metal or alkaline earth metal salt of an amino compound; a polyol of molecular weight ranging from 76 to 300; and no more than 10% water. | 2013-01-31 |
20130030200 | FATTY ACYL AMIDO BASED SURFACTANT CONCENTRATES - A surfactant concentrate is provided that includes C | 2013-01-31 |
20130030201 | METHOD FOR PREPARING FATTY ACYL AMIDO CARBOXYLIC ACID BASED SURFACTANTS - A process is provided for preparing C | 2013-01-31 |
20130030202 | METHOD FOR PREPARING FATTY ACYL AMIDO CARBOXYLIC ACID BASED SURFACTANTS - A process is provided for preparing C | 2013-01-31 |
20130030203 | GENERAL METHOD FOR PREPARING FATTY ACYL AMIDO BASED SURFACTANTS - A process is provided for preparing C | 2013-01-31 |
20130030204 | METHOD FOR THE MANUFACTURE OF AMINOPOLYALKYLENE PHOSPHONIC ACIDS - A method for the manufacture of aminopolyalkylene phosphonic acid of a specific general formula is described. In particular, a mixture of specifically defined ranges of reactants to wit: phosphorous acid; an amine; formaldehyde and an aminopolyalkylene phosphonic acid, having the same general formula as the compound to be manufactured, are reacted to thus yield a product of outstanding selectivity and purity with substantially reduced levels of non-desirable by-products. | 2013-01-31 |
20130030205 | METHOD AND APPARATUS FOR ESTERIFYING FATTY ACID - A method of esterifying free fatty acid in natural oil comprises heating the natural oil ( | 2013-01-31 |
20130030206 | RECYCLABLE SUPERPARAMAGNETIC NANOPARTICLES AND METHOD FOR PRODUCING THE SAME - A superparamagnetic nanoparticle is comprised of superparamagnetic nanocrystals less than 20 nm in size, and molecules having containing 3 to 5 carboxyl groups, wherein the molecules bond to surfaces of the superparamagnetic nanocrystals. A method for producing superparamagnetic nanoparticles includes preparing an alkaline solution with pH 10 to 14, producing a mixture in which molecules containing 3 to 5 carboxyl groups, a divalent transition metal and ferric precursors are dissolved, and adding the mixture into the alkaline solution. | 2013-01-31 |
20130030207 | PREPARATION OF SUBSTANTIALLY QUATERNIZED AMMONIUM ORGANOSILANE COMPOSITION AND SELF-STABILIZING AQUEOUS SOLUTION THEREOF - This invention relates to the preparation of a partially quaternized ammonium organosilane composition, and a self-stabilizing aqueous solution of said composition, which serves to yield an antimicrobial polysilsesquioxane coating upon thermal curing. By way of this invention, an aqueous solution is prepared, comprised in part by a partially quaternized ammonium organosilane hydrolysate, characterized in that no further manipulation or addition of potentially costly ingredients are required to yield a stable and hence marketable product. | 2013-01-31 |
20130030208 | DIHYDROXYPROPYLAMIDE-MODIFIED POLYSILOXANE COMPOUND - A modified polysiloxane compound is represented by following Formula (1), in which R | 2013-01-31 |
20130030209 | PHOSPHINATE RUTHENIUM COMPLEXES - Provided herein are ruthenium complexes of Formula I, and processes of preparation thereof. Also provided are methods of their use as a metathesis catalyst. | 2013-01-31 |
20130030210 | METHODS FOR PREPARING AMIDES AND AMINO ACIDS - The invention provides novel compounds and methods to carry out organocatalytic Michael additions of aldehydes to nitroethylene catalyzed by a proline derivative to provide α-substituted-γ-nitroaldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96-99% e.e.). The Michael adducts can bear a single substituent or dual substituents adjacent to the carbonyl. The Michael adducts can be efficiently converted to protected γ | 2013-01-31 |
20130030211 | BICYCLOHEXANE DERIVATIVE COMPOUND AND MANUFACTURING METHOD OF THE SAME - A bicyclohexane derivative compound useful in the field of photoresist, the field of intermediate of drugs and pesticides, and the like, and a manufacturing method of the same are provided. A bicyclohexane derivative compound represented by the following general formula (II) is provided. | 2013-01-31 |
20130030212 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER - Provided are an alicyclic structure-containing compound, a (meth)acrylate, and a method for producing the ester. The compound and the ester are useful as a monomer and the like for a photoresist used in semiconductor manufacturing and excellent in solubility, compatibility, defect reduction, roughness improvement, and the like, realized by using an alicyclic structure-containing compound containing a linking group having an ester bond and/or a linking group having an ether bond, a (meth)acrylate derived from the alicyclic structure-containing compound, and a method for producing the ester. | 2013-01-31 |
20130030213 | METHODS OF ISOLATING 4-CHLORO-2-FLUORO-3-SUBSTITUTED-PHENYLBORONIC ACIDS - Provided herein are methods of isolating a 4-chloro-2-fluoro-3-substituted-phenylboronic acid. The method comprises contacting a mixture of water, a water miscible organic solvent, and a 4-chloro-2-fluoro-3-substituted-phenylboronic acid with a salt to form a water miscible organic solvent layer and a water layer. The 4-chloro-2-fluoro-3-substituted-phenylboronic acid is partitioned into the water miscible organic solvent layer, which is separated from the water layer. Additional methods are disclosed, as is a 4-chloro-2-fluoro-3-substituted-phenylboronic acid produced by one of the methods, wherein the 4-chloro-2-fluoro-3-substituted-phenylboronic acid is obtained at a yield of greater than approximately 90%. | 2013-01-31 |
20130030214 | PROCESS FOR THE PREPARATION OF ADAPALENE AND RELATED COMPOUNDS - The invention provides an improved process for the preparation of a benzonaphthalene derivative including, in particular, the manufacture of high purity adapalene. The invention further includes a method for assessing the color of adapalene by means of a quantitative colorimetric measurement of the produced adapalene. | 2013-01-31 |
20130030215 | Methods for Producing Isomers of Muconic Acid and Muconate Salts - A method for producing cis,trans- and trans,trans-isomers of muconate by providing cis,cis-muconate produced from a renewable carbon source through biocatalytic conversion; isomerizing cis,cis-muconate to cis,trans-muconate under reaction conditions in which substantially all of the cis,cis-muconate is isomerized to cis,trans-muconate; separating the cis,trans-muconate; and crystallizing the cis,trans-muconate. The cis,trans-isomer can be further isomerized to the trans,trans-isomer. In one example, the method includes culturing recombinant cells that express 3-dehydroshikimate dehydratase, protocatechuate decarboxylase and catechol 1,2-dioxygenase in a medium comprising the renewable carbon source and under conditions in which the renewable carbon source is converted to 3-dehydroshikimate by enzymes in the common pathway of aromatic amino acid biosynthesis of the cell, and the 3-dehydroshikimate is biocatalytically converted to cis,cis-muconate. | 2013-01-31 |
20130030216 | PROCESS FOR THE PREPARATION OF LACOSAMIDE - A novel process for the synthesis of Lacosamide using D,L-serine as starting material is described, where the methylation reaction of hydroxyl is carried out using an inexpensive base such as NaOH and an inexpensive alkylating agent, non-toxic and non-carcinogenic, such as methyl p-toluenesulfonate; the R enantiomer is isolated from the racemic mixture of Lacosamide after selective hydrolysis of the acetamide, salification of the racemic mixture with a chiral acid (HX*) in an organic solvent, resolution of the diastereoisomeric mixture, preferably by precipitation of the R enantiomer, and subsequent acetylation of the optically pure intermediate. | 2013-01-31 |
20130030217 | METHOD FOR PRODUCING SELECTIVELY FUNCTIONALIZED CARBON NANOTUBES - Disclosed is a novel method for the selective molecular conversion of raw material carbon nanotubes containing a mixture of metallic carbon nanotubes and semiconductive carbon nanotubes in a manner that is based on the electrical properties or diameter of the carbon nanotubes. | 2013-01-31 |
20130030218 | METHOD FOR PRODUCING ZEAXANTHIN BY FERMENTATION - A method for microbiologically producing zeaxanthin at high concentration and low cost while suppressing production of gluconic acid is presented. Specifically, a method for producing carotenoids containing zeaxanthin by culturing a bacterium producing carotenoids containing zeaxanthin in a medium containing biotin is provided. | 2013-01-31 |
20130030219 | PROCESS FOR THE PREPARATION OF 1,4-CYCLOHEXANEDIMETHANOL - Disclosed is a process for the preparation of 1,4-cyclohexanedimethanol from terephthalic acid. Terephthalic acid is esterified with (4-methylcyclohexyl)methanol and the terephthalate ester hydrogenated to 1,4-cyclohexanedimethanol in a 2-stage process. The (4-methylcyclohexyl)methanol that is formed during the hydrogenation step is recycled to the esterification reaction. After removal of the (4-methylcyclohexyl)methanol from the crude hydrogenation product, the 1,4-cyclohexanedimethanol product can be recovered and purified by a phase separation and distillation. | 2013-01-31 |
20130030220 | INTEGRATED PROCESS FOR THE PREPARATION OF 1,4-CYCLOHEXANEDIMETHANOL FROM TEREPHTHALIC ACID - Disclosed is an integrated process for the preparation of 1,4-cyclohexanedimethanol from terephthalic acid. Terephthalic acid is esterified with (4-methylcyclohexyl)methanol and the terephthalate ester hydrogenated to 1,4-cyclohexanedimethanol in a 2-stage process. The (4-methylcyclohexyl)methanol that is formed during the hydrogenation step is recycled to the esterification reaction. Also disclosed is a method for purifying and recovering the 1,4-cyclohexanedimethanol product. | 2013-01-31 |
20130030221 | PROCESS FOR THE PREPARATION OF 1,4-CYCLOHEXANEDIMETHANOL FROM TEREPHTHALIC ACID - Disclosed is a process for the preparation of 1,4-cyclohexanedimethanol from terephthalic acid. Terephthalic acid is esterified with (4-methylcyclohexyl)methanol and the terephthalate ester hydrogenated to 1,4-cyclohexanedimethanol in a 2-stage process. The (4-methylcyclohexyl)methanol that is formed during the hydrogenation step is recycled to the esterification reaction. Also disclosed is a method for purifying and recovering the 1,4-cyclohexanedimethanol product. | 2013-01-31 |
20130030222 | PROCESS FOR THE PREPARATION OF 1,3-CYCLOHEXANEDIMETHANOL FROM ISOPHTHALIC ACID - Disclosed is a process for the preparation of 1,3-cyclohexanedimethanol from isophthalic acid. Isophthalic acid is esterified with (3-methylcyclohexyl)methanol and the isophthalate ester hydrogenated to 1,3-cyclohexanedimethanol in a 2-stage process. The (3-methylcyclohexyl)methanol that is formed during the hydrogenation step is recycled to the esterification reaction. Also disclosed is a method for purifying and recovering the 1,3-cyclohexanedimethanol product. | 2013-01-31 |
20130030223 | METHOD OF MAKING ALKYLENE GLYCOLS - Herein disclosed is a method of hydrating an alkylene oxide that includes introducing an alkylene oxide into water to form a first stream; flowing the first stream through a high shear device to produce a second stream; and contacting the second stream with a catalyst in a reactor to hydrate the alkylene oxide and form an alkylene glycol. | 2013-01-31 |